RATIO-MINOCYCLINE CAPSULE

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE)

から入手可能:

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

ATCコード:

J01AA08

INN（国際名）:

MINOCYCLINE

投薬量:

50MG

医薬品形態:

CAPSULE

構図:

MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) 50MG

投与経路:

ORAL

パッケージ内のユニット:

100

処方タイプ:

Prescription

治療領域:

TETRACYCLINES

製品概要:

Active ingredient group (AIG) number: 0131309001; AHFS:

認証ステータス:

CANCELLED POST MARKET

承認日:

2014-09-19

製品の特徴

PRESCRIBING INFORMATION
RATIO-MINOCYCLINE
(MINOCYCLINE HYDROCHLORIDE)
50 MG AND 100 MG CAPSULES
ANTIBIOTIC
ratiopharm inc.
DATE OF PREPARATION:
Canada, J7J 1P3
2002.04.29
DATE OF REVISION:
2010.12.17
Control #: 143043
Page 2
COMPLETE
PRESCRIBING INFORMATION
ratio-MINOCYCLINE
(minocycline hydrochloride)
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION
RATIO-MINOCYCLINE (minocycline hydrochloride) is a tetracycline with
antibacterial activity
against
some
Gram-negative
and
Gram-positive
organisms.
The
action
of
RATIO-
MINOCYCLINE is primarily bacteriostatic and it is thought to exert its
antimicrobial effect by
the inhibition of protein synthesis.
INDICATIONS AND CLINICAL USE
RATIO-MINOCYCLINE (minocycline hydrochloride) may be indicated for the
treatment of the
following infections due to susceptible strains of the designated
organisms:
Gall bladder infections caused by _Escherichia coli_.
Urinary tract infections: cystitis, gonorrhea, pyelonephritis caused
by _ Escherichia coli_,
_Proteus_ species, _Klebsiella_ species, _Enterobacter aerogenes_,
_Neisseria gonorrhea_.
When
penicillin
is
contraindicated,
RATIO-MINOCYCLINE
may
be
employed
as
an
alternative drug in the treatment of anal and pharyngeal gonorrhea and
syphilis.
Page 3
Skin and soft tissue infections: abscess, cellulitis, furunculosis,
impetigo and pyoderma
caused
by:
_Staphylococcus _
_epidermidis_,
_Staphylococcus _
_aureus_,
_Streptococcus _
_pyogenes_, _Proteus_ species, _Escherichia coli_. Although
tetracyclines are not the drugs of
choice in any staphylococcal or streptococcal infection,
RATIO-MINOCYCLINE could be
useful in circumstances where these organisms are shown to be
resistant to other agents
but sensitive to RATIO-MINOCYCLINE. Bacterial evaluation of clinical
cases involving
_Proteus_ suggests a relatively lower success rate may be expected
where these organisms
are concerned.
Respiratory
tract
infections:
bronchitis,
pharyngitis,
pneumonia,
bronchopneumonia,
sinusitis
and
tonsillitis
caused
by:
_Haemophilus _
_influenzae_,
_Klebsiella_
speci